Research-intensive cancer care in the NHS in the UK

被引:9
作者
Cameron, D. [1 ]
Stead, M. [1 ]
Lester, N. [1 ]
Parmar, M. [1 ]
Haward, R. [1 ]
Maughan, T. [1 ]
Wilson, R. [1 ]
Spaull, A. [1 ]
Campbell, H. [1 ]
Hamilton, R. [1 ]
Stewart, D. [1 ]
O'Toole, L. [1 ]
Kerr, D. [1 ]
Potts, V. [1 ]
Moser, R. [1 ]
Cooper, M. [1 ]
Poole, K. [1 ]
Darbyshire, J. [1 ]
Kaplan, R. [1 ]
Seymour, M. [1 ]
Selby, P. [1 ]
机构
[1] Natl Canc Res Network, Leeds, W Yorkshire, England
关键词
CLINICAL-TRIALS; UNITED-KINGDOM;
D O I
10.1093/annonc/mdr423
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In the late 1990s, in response to poor national cancer survival figures, government monies were invested to enhance recruitment to clinical cancer research. Commencing with England in 2001 and then rolling out across all four countries, a network of clinical cancer research infrastructure was created, the new staff being linked to existing clinical care structures including multi-disciplinary teams. In parallel, a UK-wide co-ordination of cancer research funders driven by the 'virtual' National Cancer Research Institute, combined to create a 'whole-system approach' linking research funders, researchers and NHS clinicians all working to the same ends. Over the next 10 years, recruitment to clinical trials and other well-designed studies, increased 4-fold, reaching 17% of the incident cancer population, the highest national rate world-wide. The additional resources led to more studies opened, and more patients recruited across the country, for all types of cancers and irrespective of additional clinical research staff in some hospitals. In 2006, a co-ordinated decision was made to increasingly focus on randomized trials, leading to increased recruitment, without any fall-off in accrual to non-randomized and observational studies. The National Cancer Research Network has supported large successful trials which are changing clinical practice in many cancers.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 11 条
[1]  
[Anonymous], POL FRAM COMM CANC S
[2]  
BERRINO F, 1999, INT AGENCY RES CANC, V151
[3]  
*CANC WORK GROUP, 1999, STAT PRIOR CANC RES
[4]   Extending the clinical research network approach to all of healthcare [J].
Darbyshire, J. ;
Sitzia, J. ;
Cameron, D. ;
Ford, G. ;
Littlewood, S. ;
Kaplan, R. ;
Johnston, D. ;
Matthews, D. ;
Holloway, J. ;
Chaturvedi, N. ;
Morgan, C. ;
Riley, A. ;
Rossor, M. ;
Kotting, P. ;
McKeith, I. ;
Smye, S. ;
Gower, J. ;
Brown, V. ;
Smyth, R. ;
Poustie, V. ;
van't Hoff, W. ;
Wallace, P. ;
Ellis, T. ;
Wykes, T. ;
Burns, S. ;
Rosenberg, W. ;
Lester, N. ;
Stead, M. ;
Potts, V. ;
Johns, C. ;
Campbell, H. ;
Hamilton, R. ;
Sheffield, J. ;
Selby, P. .
ANNALS OF ONCOLOGY, 2011, 22 :36-43
[5]   Pattern of care and impact of participation in clinical studies on the outcome in ovarian cancer [J].
du Bois, A ;
Rochon, J ;
Lamparter, C ;
PFisterer, J .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (02) :183-191
[6]   Better outcomes for patients treated at hospitals that participate in clinical trials [J].
Majumdar, Sumit R. ;
Roe, Matthew T. ;
Peterson, Eric D. ;
Chen, Anita Y. ;
Gibler, Brian ;
Armstrong, Paul W. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (06) :657-662
[7]   Clinical research in epithelial ovarian cancer and patients' outcome [J].
Rochon, J. ;
du Bois, A. .
ANNALS OF ONCOLOGY, 2011, 22 :16-19
[8]   The impact of the process of clinical research on health service outcomes [J].
Selby, P. ;
Autier, P. .
ANNALS OF ONCOLOGY, 2011, 22 :5-9
[9]   United Kingdom becomes the cancer clinical trials recruitment capital of the world [J].
Sinha, Gunjan .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (06) :420-+
[10]   Strengthening clinical cancer research in the United Kingdom [J].
Stead, M. ;
Cameron, D. ;
Lester, N. ;
Parmar, M. ;
Haward, R. ;
Kaplan, R. ;
Maughan, T. ;
Wilson, R. ;
Campbell, H. ;
Hamilton, R. ;
Stewart, D. ;
O'Toole, L. ;
Kerr, D. ;
Potts, V. ;
Moser, R. ;
Darbyshire, J. ;
Selby, P. .
BRITISH JOURNAL OF CANCER, 2011, 104 (10) :1529-1534